Treatment of rheumatoid arthritis with flurbiprofen: a comparison with enteric-coated aspirin.

Abstract:

:Forty patients with definite or classical rheumatoid arthritis were entered for 3 months in a double-blind trial, 20 patients each on 200 mg flurbiprofen or 4.0 g enteric-coated aspirin daily. Statistically significant improvements (Page Test, p less than 0.05) on flurbiprofen were reported during the course of the study for 7 out of 20 parameters: degree of pain, duration of morning stiffness, grip strength, torquometer, Ritchie articular index, number of swollen joints and patient's overall assessment, while for aspirin a significant improvement was reported for 5 parameters: degree of pain, PIP joint size, Ritchie articular index and physician's overall assessment. The amount of improvement between flurbiprofen and enteric-coated aspirin differed significantly (Kruskal-Wallis H Test) only for 2 parameters: Ritchie articular index and number of swollen joints. In both cases the degree of improvement was greater on flurbiprofen than an aspirin. Side-effects were reported for 7 patients receiving aspirin (2 of which were severe enough that treatment had to be stopped) and for 3 patients receiving flurbiprofen. Except for 2 cases of tinnitus on aspirin, the side-effects were mostly gastro-intestinal in nature. A significant decrease was found for patients receiving aspirin. A significant increase in blood urea occurred on flurbiprofen. Most values, however, remained within normal limits. The results suggests that flurbiprofen is better tolerated and at least as effective as enteric-coated aspirin in the treatment of patients with rheumatoid arthritis.

journal_name

Curr Med Res Opin

authors

Dequeker J,Mardjuardi A

doi

10.1185/03007998109114278

subject

Has Abstract

pub_date

1981-01-01 00:00:00

pages

418-22

issue

7

eissn

0300-7995

issn

1473-4877

journal_volume

7

pub_type

临床试验,杂志文章,随机对照试验
  • Intraocular pressure lowering effect of dorzolamide/timolol fixed combination in patients with glaucoma who were unresponsive to prostaglandin analogs/prostamides.

    abstract:OBJECTIVE:To evaluate the intraocular pressure lowering effect of the dorzolamide/timolol fixed combination (DTFC) in non-responder glaucoma patients to prostaglandin analogs/prostamides (prostas). PATIENTS AND METHODS:All glaucoma patients treated with DTFC, between June 2003 and December 2005, who were unresponsive ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079906X167688

    authors: Martínez A,Sánchez M

    更新日期:2007-03-01 00:00:00

  • Phenytoin-induced gum hypertrophy in patients with epilepsy.

    abstract::One hundred and eight patients who had been taking phenytoin for a year or more, either alone or in combination with other drugs, were examined for gum hypertrophy by three observers independently. Approximately 90% of the patients showed either mild or no gum hypertrophy and severe swelling occurred in only 1%. The o...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007998809111114

    authors: Grant RH,Parsonage MJ,Barot MH

    更新日期:1988-01-01 00:00:00

  • Predictive factors of achieving therapeutic goals of hypertriglyceridemia.

    abstract:OBJECTIVES:The aim of this study was to ascertain the factors associated with non-achievement of triglyceride (TG) goals in a cohort of hypertriglyceridemic patients attending the lipid clinics of the Spanish Arteriosclerosis Society (LC-SAS). METHODS:Patients with high TG levels (>2.2 mmol/L; 200 mg/dL) were included...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究

    doi:10.1185/03007995.2013.850069

    authors: Pintó X,Valdivielso P,Perez de Juan JM,Plana N,Garcia-Arias C,Fuentes FJ,Hernández-Mijares A,Mostaza JM,Spanish Registry of Hypertriglyceridemia (Spanish Society of Arteriosclerosis, SAS).

    更新日期:2014-01-01 00:00:00

  • Abuse-deterrent opioids: an update on current approaches and considerations.

    abstract:OBJECTIVE:Abuse and misuse of prescription opioids is a significant public health concern. This review examines the strategies used to confer abuse-deterrent properties on opioid abuse-deterrent formulations (ADFs), the characteristics and supporting data for each of the available ADFs, and the role of opioid ADFs as p...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1080/03007995.2017.1419171

    authors: Pergolizzi JV Jr,Raffa RB,Taylor R Jr,Vacalis S

    更新日期:2018-04-01 00:00:00

  • The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials.

    abstract:OBJECTIVE:To determine the ability of statins to prevent the development of new-onset type 2 diabetes mellitus through a meta-analysis of randomized, controlled trials. RESEARCH DESIGN AND METHODS:A systematic literature search through November 6, 2007 was conducted to identify randomized, placebo-controlled trials of...

    journal_title:Current medical research and opinion

    pub_type: 信件,评审

    doi:10.1185/030079908x292029

    authors: Coleman CI,Reinhart K,Kluger J,White CM

    更新日期:2008-05-01 00:00:00

  • Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis.

    abstract:BACKGROUND:Thymectomy is a standard treatment of myasthenia gravis (MG). Immunomodulating agents are frequently given during the post-thymectomy latency period until complete remission is fully consolidated, but serious side effects is a relevant clinical problem for patients on long-term immunomodulating treatment. O...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/030079906X104650

    authors: Ponseti JM,Azem J,Fort JM,López-Cano M,Vilallonga R,Gamez J,Armengol M

    更新日期:2006-05-01 00:00:00

  • Zolmitriptan is effective for the treatment of persistent and recurrent migraine headache.

    abstract::Zolmitriptan is a 5-HT1B/1D receptor agonist for the acute treatment of migraine. This study examined the efficacy of a second dose of zolmitriptan for the treatment of persistent or recurrent headache. Part 1 was a randomised, placebo-controlled, double-blind evaluation of 2.5 mg and 5 mg zolmitriptan for the treatme...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1185/03007999909116498

    authors: Mauskop A,Farkkila M,Hering-Hanit R,Rapoport A,Warner J

    更新日期:1999-01-01 00:00:00

  • Disintegration/dissolution profiles of copies of Fosamax (alendronate).

    abstract:OBJECTIVE:Poor quality has been reported for some generics and other copies of original products. We performed a pilot study to compare the disintegration/dissolution profiles of FOSAMAX (alendronate) 70 mg tablets with those of copies of FOSAMAX that were manufactured outside the United States. RESEARCH DESIGN AND ME...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079903125002577

    authors: Epstein S,Cryer B,Ragi S,Zanchetta JR,Walliser J,Chow J,Johnson MA,Leyes AE

    更新日期:2003-01-01 00:00:00

  • Recombinant luteinizing hormone supplementation to recombinant follicle stimulating hormone therapy in gonadotropin releasing hormone analogue cycles: what is the evidence?

    abstract:OBJECTIVE:To look into current evidence exploring the added value of rLH supplementation to rFSH in GnRH analogues cycles, to identify groups of women that still have no evidence for adjuvant rLH therapy and to discuss ways that may advance research on this topic. METHODS:Eight systematic reviews and meta-analyses exp...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2017.1417827

    authors: Younis JS,Laufer N

    更新日期:2018-05-01 00:00:00

  • Gastroduodenal toxicity of low-dose acetylsalicylic acid: a comparison with non-steroidal anti-inflammatory drugs.

    abstract:BACKGROUND:Low-dose acetylsalicylic acid (ASA; aspirin; 75-325 mg/day) is effective for the prevention of cardiovascular events, and its use in this indication is rapidly increasing. However, the use of ASA and, indeed, other non-steroidal anti-inflammatory drugs (NSAIDs) is limited by the incidence of adverse gastrodu...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007990903212682

    authors: Yeomans ND,Hawkey CJ,Brailsford W,Naesdal J

    更新日期:2009-11-01 00:00:00

  • Efficacy of Rhizophora mangle aqueous bark extract (RMABE) in the treatment of aphthous ulcers: a pilot study.

    abstract:OBJECTIVE:Rhizophora mangle aqueous bark extract (RMABE) (CIKRON-H), has been used as antiseptic and skin wound healing promoter. The present study was a randomised, single-blinded, placebo control trial conducted to asses the efficacy of RMABE in treating oral aphthous ulcers. RESEARCH DESIGN AND METHODS:Patients (n ...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/030079905X65493

    authors: de Armas E,Sarracent Y,Marrero E,Fernández O,Branford-White C

    更新日期:2005-11-01 00:00:00

  • Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.

    abstract:OBJECTIVE:Decision aids (DAs) are increasingly used to operationalize shared decision-making (SDM) but their development is not often described. Decisions about oral anticoagulants (OACs) for atrial fibrillation (AF) involve a trade-off between lowering stroke risk and increasing OAC-associated bleeding risk, and consi...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2015.1096767

    authors: Kaiser K,Cheng WY,Jensen S,Clayman ML,Thappa A,Schwiep F,Chawla A,Goldberger JJ,Col N,Schein J

    更新日期:2015-12-01 00:00:00

  • Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.

    abstract:INTRODUCTION:Azelastine hydrochloride (Astelin) nasal spray 0.1% solution is a second-generation intranasal antihistamine available in the US for treatment of both seasonal allergic rhinitis (SAR) and nonallergic vasomotor rhinitis (VMR). SCOPE:Searches of journal articles including the title word 'azelastine' from 19...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/030079907X226302

    authors: Bernstein JA

    更新日期:2007-10-01 00:00:00

  • Atorvastatin plus pravastatin for the treatment of heterozygous familial hypercholesterolaemia--a pilot study.

    abstract::The most common side-effect of statins, mainly during dose titration, is liver toxicity, In these cases, sufficient control of low density lipoprotein cholesterol (LDL-C) in patients with heterozygous familial hypercholesterolaemia (HFH) becomes problematical. In patients with intolerance to resins as well, especially...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:

    authors: Athyros VG,Papageorgiou AA,Demitriadis DS,Kontopoulos AG

    更新日期:2001-01-01 00:00:00

  • Counting the costs of overweight and obesity: modeling clinical and cost outcomes.

    abstract:OBJECTIVE:To quantify changes in clinical and cost outcomes associated with increasing levels of body mass index (BMI) in a US setting. RESEARCH METHODS AND PROCEDURES:A semi-Markov model was developed to project and compare life expectancy (LE), quality-adjusted life expectancy (QALE) and direct medical costs associa...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079906X96227

    authors: Tucker DM,Palmer AJ,Valentine WJ,Roze S,Ray JA

    更新日期:2006-03-01 00:00:00

  • Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study.

    abstract:OBJECTIVE:Painful physical symptoms are common in patients with major depressive disorder (MDD) and can negatively affect patient outcomes. Duloxetine has demonstrated efficacy in treating MDD and other certain painful conditions; this study specifically evaluated patients with both MDD and MDD-associated pain. METHOD...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1185/03007995.2011.609540

    authors: Gaynor PJ,Gopal M,Zheng W,Martinez JM,Robinson MJ,Hann D,Marangell LB

    更新日期:2011-10-01 00:00:00

  • Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients.

    abstract:BACKGROUND:Patients with chronic myeloid leukemia (CML) who do not adhere to treatment may experience suboptimal outcomes. OBJECTIVE:To examine the association between adherence with imatinib and direct healthcare costs and resource utilization in a large group of privately insured CML patients. PATIENTS AND METHODS:...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007990903396469

    authors: Wu EQ,Johnson S,Beaulieu N,Arana M,Bollu V,Guo A,Coombs J,Feng W,Cortes J

    更新日期:2010-01-01 00:00:00

  • Epicardial adipose tissue and atrial fibrillation: pathophysiological mechanisms, clinical implications, and potential therapies.

    abstract:BACKGROUND:Atrial fibrillation (AF) is the most common arrhythmia in clinical practice and is associated with increased cardiovascular morbidity and mortality. Epicardial adipose tissue (EAT) serves as a biologically active organ with important endocrine and inflammatory function. Review An accumulating body of evidenc...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1080/03007995.2018.1462786

    authors: Goudis CA,Vasileiadis IE,Liu T

    更新日期:2018-11-01 00:00:00

  • Modelling the economic and health consequences of cardiac resynchronization therapy in the UK.

    abstract:OBJECTIVE:Clinical evidence supports the use of cardiac resynchronization therapy (CRT) in advanced heart failure, but its cost-effectiveness is still unclear. This analysis assessed the economic and health consequences in the UK of implanting a CRT in patients with NYHA class III-IV heart failure. METHODS:A discrete ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079906X112516

    authors: Caro JJ,Guo S,Ward A,Chalil S,Malik F,Leyva F

    更新日期:2006-06-01 00:00:00

  • Economic evaluation of paliperidone palmitate once monthly for treating chronic schizophrenia patients in the United Arab Emirates.

    abstract:OBJECTIVE:Schizophrenia is one of the most debilitating diseases in the United Arab Emirates. Oral antipsychotics (OA) are commonly used in terms of pharmacotherapy; however, these treatments can be rendered ineffective by poor patient adherence. Paliperidone palmitate once monthly (PP1M) is a long acting antipsychotic...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2017.1417246

    authors: Nuhoho S,Saad A,Saumell G,Ribes D,El Khoury AC

    更新日期:2018-04-01 00:00:00

  • Improving the accuracy of medication adherence measures using linked prescription and dispensation data: findings from the ESOSVAL cohort of patients treated with osteoporosis drugs.

    abstract::Objective: We compare estimates of proportion of days covered (PDC) based on dispensation-only data versus linked prescription and dispensation information, and we analyse their differences in a real-world cohort of patients with osteoporosis.Methods: Prospective cohort study. We compared four alternative measures of ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2019.1601944

    authors: García-Sempere A,Hurtado I,Sanfélix-Genovés J,Rodríguez-Bernal C,Peiró S,Sanfélix-Gimeno G

    更新日期:2019-09-01 00:00:00

  • Racial/ethnic disparities in prevalence and care of patients with type 2 diabetes mellitus.

    abstract:BACKGROUND:As of 2012, nearly 10% of Americans had diabetes mellitus. People with diabetes are at approximately double the risk of premature death compared with those in the same age groups without the condition. While the prevalence of diabetes has risen across all racial/ethnic groups over the past 30 years, rates ar...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2015.1029894

    authors: Ferdinand KC,Nasser SA

    更新日期:2015-05-01 00:00:00

  • Targeting the pathophysiology of type 2 diabetes: rationale for combination therapy with pioglitazone and exenatide.

    abstract:OBJECTIVE:The objectives of this article are to review the pathophysiology of type 2 diabetes mellitus (T2DM), present the rationale for a pathophysiologically based treatment approach for patients with T2DM and discuss the role of the therapeutic combination of pioglitazone and exenatide in the management of T2DM. ME...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007990802390795

    authors: Schwartz S

    更新日期:2008-11-01 00:00:00

  • Results of the CAPPS: COPD--assessment of practice in primary care study.

    abstract:OBJECTIVE:Since many patients with COPD in the US are managed by primary care physicians, we evaluated adherence to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines in a primary care setting. METHODS:A cross-sectional study was conducted using a random sample of patients (n=50-150 per site)...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2013.803957

    authors: Belletti D,Liu J,Zacker C,Wogen J

    更新日期:2013-08-01 00:00:00

  • A double-blind trial of methocarbamol versus placebo in painful muscle spasm.

    abstract::A double-blind trial of methocarbamol versus placebo was carried out in 59 matched pairs of patients suffering from painful muscle spasm. Methocarbamol (1500 mg. q.d.s.) was found to be effective in approximately 60% of patients compared with 30% of patients receiving placebo (p less than 0.01). Side-effects were of a...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007997509114791

    authors: Valtonen EJ

    更新日期:1975-01-01 00:00:00

  • The determination of azapropazone in blood plasma.

    abstract::Three methods for the determination of azapropazone were studied for the analysis of blood plasma samples taken after oral administration of azapropazone. A gas chromatographic method was compared with two simple spectrophotometric assay methods and the effect of metabolites of the drug on each method is described. It...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007997609109279

    authors: Leach H

    更新日期:1976-01-01 00:00:00

  • Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.

    abstract:OBJECTIVE:The objective of this study is to provide a comprehensive estimate of the cost of ADHD by consider ing the healthcare and work loss costs of persons with ADHD, as well as those costs imposed on their family members. METHODS:Excess per capita healthcare (medical and prescription drug) and work loss (disabilit...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079904X20303

    authors: Birnbaum HG,Kessler RC,Lowe SW,Secnik K,Greenberg PE,Leong SA,Swensen AR

    更新日期:2005-02-01 00:00:00

  • Changes in metabolic parameters and body weight in brexpiprazole-treated patients with acute schizophrenia: pooled analyses of phase 3 clinical studies.

    abstract:OBJECTIVE:To analyze the effect of brexpiprazole on metabolic parameters and body weight in adults with schizophrenia, including clinically relevant sub-groups of patients, based on data from two pivotal phase 3 studies (NCT01393613; NCT01396421) and a long-term extension study (NCT01397786). METHODS:The short-term st...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析

    doi:10.1080/03007995.2018.1498779

    authors: Newcomer JW,Eriksson H,Zhang P,Weiller E,Weiss C

    更新日期:2018-12-01 00:00:00

  • Exenatide BID Observational Study (ExOS): results for primary and secondary endpoints of a prospective research study to evaluate the clinical effectiveness of exenatide BID use in patients with type 2 diabetes in a real-world setting.

    abstract:OBJECTIVE:The Exenatide BID Observational Study (ExOS) was designed to evaluate the clinical effectiveness of exenatide BID use in patients with type 2 diabetes (T2D) in a real-world clinical practice setting in the United States. METHODS:Patients were enrolled from 74 practice sites from 9/2007 through 1/2009 and fol...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1185/03007995.2011.628305

    authors: Bergenstal RM,Garrison LP Jr,Miller LA,Hou L,Blickensderfer A,Zagar A,Stanley S,Bhargava A,Wade R,Herman WH

    更新日期:2011-12-01 00:00:00

  • Economic implications of using pegfilgrastim rather than conventional G-CSF to prevent neutropenia during small-cell lung cancer chemotherapy.

    abstract:BACKGROUND:For the prevention of chemotherapy-induced febrile aplasia, a single injection of pegfilgrastim per cycle has the same efficacy as six to ten injections of conventional granulocyte colony-stimulating factor (G-CSF). However, there are few data on the economic impact of pegfilgrastim use, especially in the co...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究

    doi:10.1185/03007990902918156

    authors: Tan Sean P,Chouaid C,Hettler D,Baud M,Hejblum G,Tilleul P

    更新日期:2009-06-01 00:00:00